scholarly journals Prosthetic Valve Malfunction; Etiologies, Treatment Strategies and Treatment Outcomes: A Descriptive-analytic Study

2020 ◽  
Vol 15 (9-10) ◽  
pp. 255-261
Author(s):  
Hasan Haghaninejad ◽  
Farkhondeh Khaleghi ◽  
Aryan Naghedi
Keyword(s):  
Treatment Outcomes ◽  
Prosthetic Valve ◽  
Treatment Strategies ◽  
Analytic Study ◽  
Valve Malfunction

Giant left atrium in a woman with mitral prosthetic valve malfunction and history of rheumatic heart disease

2009 ◽  
Vol 4 (5) ◽  
pp. 435-437
Author(s):  
Gaspare Parrinello ◽  
Daniele Torres ◽  
Salvatore Paterna ◽  
Manuela Mezzero ◽  
Pietro Di Pasquale ◽  
...  
Keyword(s):  
Heart Disease ◽  
Left Atrium ◽  
Rheumatic Heart Disease ◽  
Prosthetic Valve ◽  
History Of ◽  
Giant Left Atrium ◽  
Valve Malfunction ◽  
Rheumatic Heart

scholarly journals Fibrovascular pigment epithelial detachment in eyes with subretinal hemorrhage secondary to neovascular AMD or PCV: a morphologic predictor associated with poor treatment outcomes

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Jae Hui Kim ◽  
Joo Yeon Kim ◽  
Dong Won Lee ◽  
Chul Gu Kim ◽  
Jong Woo Kim
Keyword(s):  
Treatment Outcomes ◽  
Treatment Strategies ◽  
Age Related Macular Degeneration ◽  
Subretinal Hemorrhage ◽  
Pigment Epithelial Detachment ◽  
Neovascular Amd ◽  
Pigment Epithelial ◽  
Age Related ◽  
Poor Treatment ◽  
The Mean

Abstract To evaluate the influence of fibrovascular pigment epithelial detachment (FVPED) on treatment outcomes in eyes with subretinal hemorrhage secondary to neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV). This retrospective study included 83 eyes diagnosed with fovea-involving submacular hemorrhage secondary to neovascular AMD or PCV. All the patients were treated with intravitreal anti-vascular endothelial growth factor. Eyes showing definite FVPED, which involves the subfoveal region, were included in the FVPED group. Eyes without subfoveal PED, shallow irregular PEDs, or serous/hemorrhagic PED were stratified to the non-FVPED group. The best-corrected visual acuity (BCVA) at diagnosis, at 3 months, at 12 months, and lesion re-activation after initial treatment were compared between the two groups. The mean size of hemorrhage was 8.6 ± 7.6 disc diameter areas. In the FVPED group, the mean logarithm of minimal angle of resolution BCVA was 1.11 ± 0.49 at diagnosis, 0.89 ± 0.58 at 3 months, and 1.05 ± 0.63 at 12 months. In the non-FVPED group, the values were 0.97 ± 0.56, 0.56 ± 0.55, and 0.45 ± 0.50, respectively. The BCVA at 3 months (P = 0.036) and at 12 months (P < 0.001) was significantly worse in the FVPED group than in the non-FVPED group. In addition, the incidence of lesion reactivation was greater in the FVPED group (83.3%) than in the non-FVPED group (38.5%) (P < 0.001). The presence of subfoveal FVPED was associated with a high incidence of lesion re-activation and poor treatment outcomes in eyes with subretinal hemorrhage. This result suggests that different treatment strategies are needed between eyes with and without FVPED.

Sign in / Sign up

Export Citation Format

Share Document